News | Radiation Therapy | September 26, 2016

Elekta to Highlight High Definition Dynamic Radiosurgery Solutions at ASTRO 2016

Integrated technology solution enables clinicians to address highly-complex SRS and SBRT treatments with increased confidence

Elekta, ASTRO 2016, HD Dynamic Radiosurgery, brachytherapy

September 26, 2016 — At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston, Elekta will showcase its HD Dynamic Radiosurgery that leverages the core strengths of Versa HD linear accelerator and Monaco treatment planning system.

Versa HD combines High Definition Dynamic Radiosurgery treatment capabilities and precision radiotherapy in a single platform. Equipped with sophisticated full-field, high-definition beam-shaping technology and High Dose Rate mode, Versa HD offers the precision and speed necessary to deliver versatile stereotactic treatments throughout the body. Monaco powers more efficient high-definition planning with true Monte Carlo accuracy and advanced multi-criterial optimization.

The combination of Versa HD and Monaco enables more modulation in a single arc with 1,024 dynamic control points enabling delivery of highly-conformal stereotactic radiosurgery and stereotactic body radiotherapy treatments within standard treatment slots, irrespective of complexity or anatomy.

Visitors to Elekta’s will also have an opportunity to learn more about:

  • Mosaiq Oncology Analytics, a knowledge management solution that unlocks data into actionable information to enable continuous improvement of clinical, operational and financial performance;
  • Leksell Gamma Knife Icon, the latest technological advance in Elekta’s Gamma Knife radiosurgery platform, enables precision cranial radiosurgery with online dose adaptation. Featuring sophisticated imaging and motion management technologies, Icon is making cranial radiosurgery available to more patients by offering frameless fractionated treatments with similar accuracy as frame-based single-session radiosurgery; 
  • Venezia, the company’s new gynecological applicator provides a new option for treating advanced-stage cervical cancer. Designed to support the recommendations for 3-D image-guided adaptive brachytherapy for locally advanced cervical cancer, Venezia allows clinicians to treat IIIA and IIIB tumors in the cervix, parametrium and vaginal extensions through a combination of straight and oblique needles with consistent and reproducible needle placement. (Venezia is not available for sale or distribution in all markets, is not for sale in the United States and is pending U.S. Food and Drug Administration (FDA) 510(k) clearance; and
  • Advanced imaging and motion management solutions, which allow more focused guidance for precise dose targeting and critical structure avoidance. XVI 4-D reduces margins with online automated motion guidance and increases precision through critical structure avoidance. Clarity Autoscan delivers precise intra-fraction motion management for prostate featuring continuous soft-tissue imaging.

For more information: www.elekta.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...